약물 교체가 필요한 조현병 환자에서 Paliperidone Extended Release로의 교체 후 유효성과 안전성에 관한 분석
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 문영선 | - |
dc.contributor.author | 나경세 | - |
dc.contributor.author | 김철응 | - |
dc.contributor.author | 김용식 | - |
dc.contributor.author | 윤진상 | - |
dc.contributor.author | 안용민 | - |
dc.contributor.author | 정희연 | - |
dc.contributor.author | 유범희 | - |
dc.contributor.author | 전양환 | - |
dc.contributor.author | 이상규 | - |
dc.contributor.author | 석정호 | - |
dc.contributor.author | 함병주 | - |
dc.contributor.author | 박두병 | - |
dc.contributor.author | 김현 | - |
dc.contributor.author | 이병욱 | - |
dc.contributor.author | 홍창형 | - |
dc.contributor.author | 김종우 | - |
dc.contributor.author | 한진희 | - |
dc.date.accessioned | 2021-06-18T09:44:01Z | - |
dc.date.available | 2021-06-18T09:44:01Z | - |
dc.date.issued | 2012-07 | - |
dc.identifier.issn | 1017-5717 | - |
dc.identifier.issn | 2092-5700 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/45996 | - |
dc.description.abstract | ObjectivezzThis study aimed to evaluate the clinical efficacy, safety, and tolerability of paliperidone extended release (ER) in patients with schizophrenia by switching previous antipsychotics to paliperidone ER. MethodszzAn open-label, 24 weeks, prospective, non-comparative, multi-center study evaluated total 387 patients with schizophrenia requiring a switch in antipsychotic medication due to suboptimal efficacy, intolerability, and non-compliance. Patients were switched to flexible-dose trial of paliperidone ER (3-12 mg/day). Efficacy was measured by Krawiecka Scale, Clinical Global Impression-Schizophrenia-Severity (CGI-SCH-S), Clinical Global Impression-Schizophrenia-Improvement (CGI-SCH-I), sleep visual analog scale (VAS), and Personal and Social Performance Scale (PSP). Safety assessments included adverse events (AEs), evaluation of extrapyramidal symptoms (EPS) using the Drug Induced Extrapyramidal Symptoms Scale (DIEPSS), and laboratory tests. ResultszzData from a total of 321 subjects who took the paliperidone ER and had at least one follow-up assessment without a major protocol violation were analyzed. Switching to paliperidone ER led to a significant improvement in the Krawiecka, CGI-SCH-S, CGI-SCH-I, PSP, and DIEPSS scales. However, serum prolactin levels and metabolic parameters including body weight and waist circumference were significantly increased. Insomnia was the most common adverse event. ConclusionzzThis study suggested that patients with schizophrenia who showed insufficient response or intolerance to other previous antipsychotics can be switched to paliperidone ER, with efficacy, safety, and tolerability. | - |
dc.format.extent | 10 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.publisher | 대한정신약물학회 | - |
dc.title | 약물 교체가 필요한 조현병 환자에서 Paliperidone Extended Release로의 교체 후 유효성과 안전성에 관한 분석 | - |
dc.title.alternative | Efficacy and Safety of Paliperidone Extended Release in Schizophrenia Patients Requiring a Switch in Antipsychotic Medication by Switching Previous Antipsychotics to Paliperidone Extended Release | - |
dc.type | Article | - |
dc.identifier.bibliographicCitation | 대한정신약물학회지, v.23, no.3, pp 97 - 106 | - |
dc.identifier.kciid | ART001682143 | - |
dc.description.isOpenAccess | N | - |
dc.citation.endPage | 106 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 97 | - |
dc.citation.title | 대한정신약물학회지 | - |
dc.citation.volume | 23 | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Schizophrenia | - |
dc.subject.keywordAuthor | Atypical antipsychotic | - |
dc.subject.keywordAuthor | Paliperidone ER | - |
dc.subject.keywordAuthor | Efficacy | - |
dc.subject.keywordAuthor | Tolerability. | - |
dc.subject.keywordAuthor | 조현병 | - |
dc.subject.keywordAuthor | 비정형 항정신병 약물 | - |
dc.subject.keywordAuthor | Paliperidone ER | - |
dc.subject.keywordAuthor | 효과 | - |
dc.subject.keywordAuthor | 내약성 | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.